Certara Products Archives | 第 18 页，共 22 页 | Certara

Case Study

基因治疗临床试验设计中的早期价值评估

A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…

Jim Gallagher2021 年 2 月 12 日

White Paper

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

Danielle Pillsbury2021 年 2 月 3 日

Brochure

BaseCase Interactive for Medical Affairs

Jim Gallagher2021 年 1 月 28 日

Brochure

BaseCase Market Access

Certara2020 年 11 月 30 日

Article

Getting Real with RWE

By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…

Certara2020 年 11 月 20 日

Case Study

Galderma AKLIEF®（曲法罗汀）获得了 FDA 批准

In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…

Certara2020 年 11 月 9 日

White Paper

COVID-19 对利益相关者参与和价值传播的影响：准备迎接 New Normal

Jim Gallagher2020 年 10 月 28 日

On-Demand Webinar

SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU

In this webinar, our experts provided an overview of the SNDS and the key working…

Jim Gallagher2020 年 10 月 20 日

Announcement

New Pinnacle 21 Community Validation Engine: FDA (1907.2)

In August 2020, we released our new Pinnacle 21 validation engine “FDA (1907.2)” for preparing…

Certara2020 年 9 月 13 日

On-Demand Webinar

Exploring Common CDISC ADaM Dataset Conformance Findings

What you need to know when validating your CDISC ADAM datasets During the regulatory review…

Danielle Pillsbury2020 年 9 月 3 日

© 2025 Certara. 保留所有权力。 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software